Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)

Lifecore Biomedical sets November 4, 2026 record date for merger stockholder vote

Neutral Impact 4 of 5 m&a Written later

Lifecore Biomedical's board set November 4, 2026 as the record date for a special meeting of stockholders to vote on adopting the merger agreement signed September 27, 2026. Stockholders of record at the close of business on that date will be entitled to vote, so the filing marks a step toward the shareholder vote on the pending deal.

Key points

  • Merger Agreement dated September 27, 2026, with Lifecore Inc. and Hazel Merger Sub, Inc.
  • Board set November 4, 2026 as record date for the special meeting of stockholders
  • Special meeting will vote on adopting the Merger Agreement and approving the merger
  • Company will file a preliminary proxy statement with the SEC

The filing

CompanyLIFECORE BIOMEDICAL, INC. \DE\ (LFCR)
Form8-K, current report
Filed with the SECOct 20, 2026, 4:30 PM ET
Accession number0001005286-26-000040

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:29 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 20, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.